Skip to main content

Table 2 Distribution of p16INK4a versus HPV immunoexpression in 90 cervical tumors cases according to diagnosis in women from Sudan

From: Introduction of p16INK4a as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan

Diagnosis

HPV

p16INK4a

p value£

  

Negative

n (%)

Positive

n (%)

 

SCC

Positive

3 (18.8)

4 (6.6)

0.049£

Negative

13 (81.2)

57 (93.4)

Others

Positive

1 (16.7)

1 (14.3)

0.219

Negative

5 (83.3)

6 (85.7)

Total

Positive

4 (18.2)

5 (7.4)

0.011£

Negative

18 (81.8)

63 (92.6)

  1. £significant